(Q43046702)

12 November 2017

Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro (English)

1 reference

12 November 2017

0 references

Francesco Saladini

5

0 references

Maurizio Zazzi

object named as

Maurizio Zazzi

6

0 references

Ilaria Vicenti

object named as

Ilaria Vicenti

1

0 references

Alessia Giannini

3

object named as

Alessia Giannini

1 reference

12 November 2017

Adele Boccuto

2

1 reference

PubMed ID

29113824

12 November 2017

Filippo Dragoni

4

1 reference

PubMed ID

29113824

12 November 2017

language of work or name

1 reference

4 November 2017

1 reference

12 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Virus Research

1 reference

on focus list of Wikimedia project

12 November 2017

244

0 references

page(s)

64-70

0 references

WikiProject Zika Corpus

0 references

cites work

Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus: Quantification, Propagation, Detection, and Storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Structure and functionality in flavivirus NS-proteins: perspectives for drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus Infection in Pregnant Women in Rio de Janeiro — Preliminary Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Guillain-Barré syndrome associated with Zika virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

The FDA-approved drug sofosbuvir inhibits Zika virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus Associated with Meningoencephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Drug Repurposing: New Treatments for Zika Virus Infection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Adverse effects and other safety aspects of the hepatitis C antivirals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Development of standard methods for Zika virus propagation, titration, and purification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Nucleoside inhibitors of Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

A sensitive virus yield assay for evaluation of Antivirals against Zika Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Determination of the Cell Permissiveness Spectrum, Mode of RNA Replication, and RNA-Protein Interaction of Zika Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

The Convergence of a Virus, Mosquitoes, and Human Travel in Globalizing the Zika Epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Yellow fever and Zika virus epizootics and enzootics in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus Associated with Microcephaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Cell-line dependent antiviral activity of sofosbuvir against Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Time Lags between Exanthematous Illness Attributed to Zika Virus, Guillain-Barré Syndrome, and Microcephaly, Salvador, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus and Birth Defects — Reviewing the Evidence for Causality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus Infection and Development of a Murine Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika Virus: Transmission, Detection, Control, and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika virus in Brazil and macular atrophy in a child with microcephaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

From Mosquitos to Humans: Genetic Evolution of Zika Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika virus: History, emergence, biology, and prospects for control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Zika virus: An emerging flavivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.11.003

10.1016/J.VIRUSRES.2017.11.003

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

29113824